Abiopharma

🔍 Middleton Fred A (Executive)

Company: CalciMedica, Inc. (CALC)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 248,972 shares of Common Stock at $0.8033 per share (Direct)
  Date: 2026-06-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,063,272.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Sanderling Venture Partners VI, LP | shares_owned_after: 946,744.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Sanderling Ventures Management VI | shares_owned_after: 22,479.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Sanderling VI Beteligungs GmbH & Co KG | shares_owned_after: 7,456.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Sanderling VI Limited Partnership | shares_owned_after: 8,884.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Sanderling Ventures VII, L.P. | shares_owned_after: 435,148.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Sanderling Ventures VII (Canada), L.P. | shares_owned_after: 114,260.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Sanderling Ventures VII Annex Fund, L.P. | shares_owned_after: 27,609.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Sanderling Ventures Management VII | shares_owned_after: 30,292.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: By Golden Triangle Ventures, LLC | shares_owned_after: 8,176.00 | Footnotes: F6
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: H | shares_owned_after: 36,514.00

Footnotes:

• F1: The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors.
• F2: The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP ("SVP VI Co-Investment, LP", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
• F3: The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VI Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
• F4: The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP ("SVP VII, LP", together with Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), L.P. and Sanderling Ventures VII Annex Fund, L.P., the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
• F5: The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the Sanderling VII Securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
• F6: The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.